NeoImmuneTech, Inc. (KOSDAQ: 950220)

NeoImmuneTech Income Statement

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Selling, General & Admin	42,877	52,369	55,326	50,090	8,134	6,849
Research & Development	-	-	-	-	22,704	8,592
Operating Expenses	46,707	55,847	58,182	51,906	31,270	16,224
Operating Income	-45,616	-55,847	-58,182	-51,906	-31,270	-16,224
Interest Expense	-225.28	-225.28	-261.39	-219.15	-185.79	-131.19
Interest & Investment Income	2,877	2,877	1,154	390.88	952.88	2,167
Currency Exchange Gain (Loss)	-128.89	-128.89	-3,005	-589.4	-79.28	-18.35
Other Non Operating Income (Expenses)	-901.5	23.06	18.52	15.46	0.35	14.39
EBT Excluding Unusual Items	-43,995	-53,301	-60,276	-52,308	-30,582	-14,192
Gain (Loss) on Sale of Assets	-1.91	-1.91	-13.03	-104.72	152.62	-0.96
Pretax Income	-43,997	-53,303	-60,289	-52,413	-30,429	-14,193
Income Tax Expense	16.46	101.3	116.41	69.47	27.29	5.05
Net Income	-44,014	-53,405	-60,406	-52,482	-30,456	-14,198
Net Income to Common	-44,014	-53,405	-60,406	-52,482	-30,456	-14,198
Shares Outstanding (Basic)	99	99	99	95	83	81
Shares Outstanding (Diluted)	99	99	99	95	83	81
Shares Change (YoY)	0.03%	0.08%	3.68%	15.26%	1.50%	39.27%
EPS (Basic)	-445.18	-540.26	-611.60	-550.94	-368.52	-174.37
EPS (Diluted)	-445.18	-540.26	-611.60	-550.94	-368.52	-174.37
Free Cash Flow	-41,739	-50,552	-44,881	-36,596	-29,993	-15,221
Free Cash Flow Per Share	-422.17	-511.41	-454.42	-384.18	-362.92	-186.94
EBITDA	-42,101	-52,637	-55,380	-50,033	-30,282	-15,443
D&A For EBITDA	3,515	3,210	2,802	1,873	987.98	780.79
EBIT	-45,616	-55,847	-58,182	-51,906	-31,270	-16,224

Source: S&P Capital IQ. Standard template. Financial Sources.